Publication | Closed Access
Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.
14
Citations
0
References
2015
Year
Tumor ImmunologyCancer ImmunosurveillanceExciting New ClassMedicineMutation-derived Tumor AntigensImmunologyTumor ImmunityTherapeutic VaccineImmune Checkpoint InhibitorCancer VaccinesImmune Cell TherapyImmunotherapyOncologyRadiation OncologyCancer ResearchMutation-derived Tumor
Because of the abundance of promising preclinical and early-phase clinical data, mutation-derived tumor antigens an exciting new class of targets in cancer immunotherapy.